Novel, low-cost bioreactor for in vitro electrical stimulation of cardiac cells
By offering a standardized platform for ES-based cardiomyocyte maturation, this bioreactor aims to accelerate advancements in cardiac tissue engineering. Future research will explore how variations in ES parameters influence cardiomyocyte phenotype and maturation, contributing to a deeper understanding of cardiac cell development and optimization for therapeutic applications.
Authors
- Peter I. Lelkes (ORCID: https://orcid.org/0000-0003-4954-3498)
- Joseph P. Licata (ORCID: https://orcid.org/0000-0002-8749-5952)
- Jonathan A. Gerstenhaber (ORCID: https://orcid.org/0000-0002-8162-7977)
Institutions
- Temple University (US)
Publication Details
- Journal
- Frontiers in Bioengineering and Biotechnology
- Published
- 2025-02-03
- DOI
- https://doi.org/10.3389/fbioe.2025.1531731
- Citations
- 6
- Primary Topic
- Neuroscience and Neural Engineering
- Type
- article
- Field-Weighted Citation Impact
- 5.45